| MediciNova Management to Host a Conference Call to Discuss 2011 Earnings ... MarketWatch (press release) MediciNova's pipeline includes six clinical-stage compounds for the treatment of acute exacerbations of asthma, chronic obstructive pulmonary disease exacerbations, multiple sclerosis and other neurologic conditions, asthma, interstitial cystitis, ... See all stories on this topic » |
| MediciNova completes enrollment in Phase II asthma trial Pharmaceutical Business Review MediciNova has completed enrollment in its Phase II trial (MN-221-CL-007) evaluating the safety and efficacy of MN-221 for treatment of acute exacerbations of asthma. The randomized, double-blind trial enrolled a total of 176 asthma patients in the ... See all stories on this topic » |
| Aerocrine's novel asthma test in search of doctors, insurers News & Observer "If you can promote patient adherence to medication you can eliminate ER visits, acute care and hospitalizations," Brown said. "There are many patients with chronic coughs treated for asthma – sometimes aggressively and expensively – and I question ... See all stories on this topic » |
Friday, March 23, 2012
Acute asthma treatment
Labels:
asthma treatment
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment